Sacyr, S.A.

Earnings are set to grow faster than sales (EPS about 9%/yr vs revenue 3%/yr), so margins should widen.

Revenue grew 0.9%/yr over the last 3 years and is set to keep growing around 3%/yr.

Growth is the weak spot here, trailing 100% of companies worldwide.

Revenue grew 0.9%/yr over the last 3 years, behind 70% of companies worldwide.3/10

Revenue is set to grow 3%/yr over the next 3 years, behind most of the market.2/10

Over five years revenue is set to grow 1%/yr, behind 90% of companies worldwide.1/10

Growth is a weak point here. The one thing to watch: the 3-year revenue record is weak.

Strong long-term results. Long-term holders have seen +58% over three years and +106% over five, ahead of 60% of the market.

It's up 9% over the past year, but 20% below its 52-week high. That is a touch ahead of the market.

Returns sit at the market level so far this year (+4%).

The stock is underperforming over the past month (-10%) and over three months (-16%).

A proven multi-year compounder now in a meaningful pullback well below its 52-week high. This is the classic fork: either a buy-the-dip in an intact uptrend, or the early stage of a trend change. Wait for the short-term slide to stabilise before adding. The one thing to watch: the stock is underperforming over the past month and over three months.